MRI in Staging Ovarian Cancer Using MRI Contrast Agent
Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Can MRI be used to stage ovarian cancer?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2007
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 18, 2007
CompletedFirst Posted
Study publicly available on registry
April 20, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedApril 20, 2007
April 1, 2007
April 18, 2007
April 18, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- suspicion of ovarian cancer
You may not qualify if:
- recurrence of disease
- contraindication to MRI, contrast agent
- inoperable patients for other reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liselotte Ibsen, doc
Aarhus University Hospital, BDA, Skejby
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 18, 2007
First Posted
April 20, 2007
Study Start
April 1, 2007
Study Completion
April 1, 2008
Last Updated
April 20, 2007
Record last verified: 2007-04